Advanced Cell concludes an early-stage trial of its myoblast program

09/29/2010 | Mass High Tech (Boston)

Advanced Cell Technology plans to launch a midstage trial of its myoblast therapy during the first half of 2011, after finishing a Phase I study in heart failure patients. The Phase II trial will test the myoblast program, which involves the use of adult progenitor stem cells derived from a biopsy of skeletal muscle, in patients who are not fit to undergo bypass surgery or angioplasty.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD